Loss of heterozygosity of APC and DCC tumor suppressor genes in human sporadic colon cancer
被引:16
作者:
Sturlan, S
论文数: 0引用数: 0
h-index: 0
机构:Rudjer Boskovic Inst, Div Mol Med, HR-10000 Zagreb, Croatia
Sturlan, S
Kapitanovic, S
论文数: 0引用数: 0
h-index: 0
机构:Rudjer Boskovic Inst, Div Mol Med, HR-10000 Zagreb, Croatia
Kapitanovic, S
Kovacevic, D
论文数: 0引用数: 0
h-index: 0
机构:Rudjer Boskovic Inst, Div Mol Med, HR-10000 Zagreb, Croatia
Kovacevic, D
Lukac, J
论文数: 0引用数: 0
h-index: 0
机构:Rudjer Boskovic Inst, Div Mol Med, HR-10000 Zagreb, Croatia
Lukac, J
Spaventi, S
论文数: 0引用数: 0
h-index: 0
机构:Rudjer Boskovic Inst, Div Mol Med, HR-10000 Zagreb, Croatia
Spaventi, S
Spaventi, R
论文数: 0引用数: 0
h-index: 0
机构:Rudjer Boskovic Inst, Div Mol Med, HR-10000 Zagreb, Croatia
Spaventi, R
Pavelic, K
论文数: 0引用数: 0
h-index: 0
机构:Rudjer Boskovic Inst, Div Mol Med, HR-10000 Zagreb, Croatia
Pavelic, K
机构:
[1] Rudjer Boskovic Inst, Div Mol Med, HR-10000 Zagreb, Croatia
[2] Croatian Acad Sci & Arts, Zagreb, Croatia
[3] Univ Zagreb, Clin Hosp Sestre Milosrdnice, HR-10002 Zagreb, Croatia
[4] PLIVA Res Inst, Zagreb, Croatia
来源:
JOURNAL OF MOLECULAR MEDICINE-JMM
|
1999年
/
77卷
/
03期
关键词:
colon cancer;
tumor suppressor genes;
APC;
DCC;
loss of heterozygosity;
D O I:
10.1007/s001090050357
中图分类号:
Q3 [遗传学];
学科分类号:
071007 ;
090102 ;
摘要:
We examined 36 cases of human sporadic colon carcinoma and corresponding normal tissue samples to evaluate loss of heterozygosity at the APC and DCC tumor suppressor genes loci using restriction fragment length polymorphism polymerase chain reaction and variable nucleotide tandem repeat analysis. Observed informativity was 83% for APC and 75% for DCC. DNA from 6 (20%) of 30 informative tumors exhibited loss of heterozygosity at the APC locus. Loss of heterozygosity at the DCC locus was observed in 7 (26%) of 27 informative tumor DNAs. Our results support the view that malignant progression is a consequence of more than one genetic change and suggest that inactivation of APC and DCC genes plays a role in a multistep process of colon tumor progression.